Anisocoria

2019 ◽  
pp. 187-192
Author(s):  
Matthew J. Thurtell ◽  
Robert L. Tomsak

A difference in the size of the pupils (anisocoria) is a frequent finding on physical examination. While often a cause for alarm, it is not uncommonly physiologic. In this chapter, we begin by reviewing the innervation of the iris sphincter and dilator muscles. We next introduce clinical strategies that can help to determine the etiology of anisocoria. We describe the components of the pupil examination, which includes an evaluation of pupil size in bright light compared to darkness, as well as evaluation of the pupil shape, response to light, and response to near. We include an algorithm that summarizes the clinical approach to anisocoria. Lastly, we review the clinical features of physiologic anisocoria, which occurs in up to 20% of the normal population and does not require further diagnostic testing.

Author(s):  
Teneille Emma Gofton

Delirium affects a diverse patient population, may present with highly variable clinical features, is a source of distress for patients and their caregivers, prolongs hospital stays and may herald a poor prognosis. Many cases of delirium are reversible and therefore a full history, physical examination and investigations should be performed. A high degree of suspicion is required for detecting delirium and thorough investigations are necessary in order to determine the underlying etiology and to maximize the potential for reversibility. The following review outlines important aspects of a clinical approach to delirium, the differential diagnosis of delirium, investigation of a patient presenting with delirium, management of delirium, the pathophysiology of delirium and the prognosis accompanying delirium.


2020 ◽  
Vol 7 (Supplement_1) ◽  
pp. S296-S297
Author(s):  
Trini A Mathew ◽  
Jonathan Hopkins ◽  
Diane Kamerer ◽  
Shagufta N Ali ◽  
Daniel Ortiz ◽  
...  

Abstract Background The novel Coronavirus SARS CoV-2 (COVID-19) outbreak was complicated by the lack of diagnostic testing kits. In early March 2020, leadership at Beaumont Hospital, Royal Oak Michigan (Beaumont) identified the need to develop high capacity testing modalities with appropriate sensitivity and specificity and rapid turnaround time. We describe the molecular diagnostic testing experience since initial rollout on March 16, 2020 at Beaumont, and results of repeat testing during the peak of the COVID-19 pandemic in MI. Methods Beaumont is an 1100 bed hospital in Southeast MI. In March, testing was initially performed with the EUA Luminex NxTAG CoV Extended Panel until March 28, 2020 when testing was converted to the EUA Cepheid Xpert Xpress SARS-CoV-2 for quicker turnaround times. Each assay was validated with a combination of patient samples and contrived specimens. Results During the initial week of testing there was > 20 % specimen positivity. As the prevalence grew the positivity rate reached 68% by the end of March (Figure 1). Many state and hospital initiatives were implemented during the outbreak, including social distancing and screening of asymptomatic patients to increase case-finding and prevent transmission. We also adopted a process for clinical review of symptomatic patients who initially tested negative for SARS-CoV-2 by a group of infectious disease physicians (Figure 2). This process was expanded to include other trained clinicians who were redeployed from other departments in the hospital. Repeat testing was performed to allow consideration of discontinuation of isolation precautions. During the surge of community cases from March 16 to April 30, 2020, we identified patients with negative PCR tests who subsequently had repeat testing based on clinical evaluation, with 7.1% (39/551) returning positive for SARS- CoV2. Of the patients who expired due to COVID-19 during this period, 4.3% (9/206) initially tested negative before ultimately testing positive. Figure 1 BH RO testing Epicurve Figure 2: Screening tool for repeat COVID19 testing and precautions Conclusion Many state and hospital initiatives helped us flatten the curve for COVID-19. Our hospital testing experience indicate that repeat testing may be warranted for those patients with clinical features suggestive of COVID-19. We will further analyze these cases and clinical features that prompted repeat testing. Disclosures All Authors: No reported disclosures


2011 ◽  
pp. 147-151
Author(s):  
Matthew J. Thurtell ◽  
Robert L. Tomsak ◽  
Robert B. Daroff

A difference in the size of the pupils (anisocoria) is a frequent finding on physical examination. While often a cause for alarm, it is not uncommonly physiologic and of no concern. In this chapter, we summarize the approach to the patient with anisocoria.


2020 ◽  
Vol 48 (9) ◽  
pp. 030006052095782
Author(s):  
Xiaolei Xie ◽  
Fuguang Li ◽  
Weihe Tan ◽  
Jiang Tang

Objective The pericentric inversion of chromosome 9 (inv9) is one of the most common structural balanced chromosomal variations, and it is considered to be a normal population variant. The aim of this study was to re-evaluate the clinical impact of patients with inv9. Methods We studied the karyotypes from 4853 patients at a single center and retrospectively reviewed their clinical data. Results There were 67 inv9 patients among 2988 adults, and 62 of them showed different clinical features, including male and female infertility, oligoasthenozoospermia, and azoospermia. Thirty-one cases of inv9 were found in 1865 fetuses, including two cases in chorionic villus (6.90%) and 29 in amniotic fluid (1.67%), but there were no cases in umbilical cord blood. The rates of fetal phenotype abnormal and adverse pregnancy outcome with inv9 in the chorionic villus were 100.00% (2/2), while only 17.24% (5/29) in the amniotic fluid showed abnormalities, among which 60.00% (3/5) had adverse pregnancy outcomes. Conclusions Although there is no clear evidence that inv9 is pathogenic, the genetic counseling on inv9 in early pregnancy and adults needs to be given more attention.


2013 ◽  
Vol 04 (03) ◽  
pp. 061-070 ◽  
Author(s):  
Prashanth Prabakaran ◽  
Nalini Guda ◽  
Jacob Thomas ◽  
Charles Heise ◽  
Deepak Gopal

AbstractObscure gastrointestinal bleeding (OGIB) can present as a diagnostic dilemma and management can be challenging. The search for causes of OGIB is usually centered on visualizing the small bowel, and in the past decade, the technology to visualize the entire small bowel has significantly advanced. Moreover, small bowel endoscopic imaging has replaced, in many instances, prior radiographic evaluation for obscure GI bleeding. These new modalities, such as small bowel capsule endoscopy (CE), balloon-assisted deep enteroscopy [double balloon enteroscopy (DBE) and single balloon enteroscopy (SBE)], and overtube-assisted deep enteroscopy (spiral enteroscopy), are paving the way toward more accurately identifying and treating patients with OGIB. We will review the diagnostic modalities available in evaluating a patient with OGIB and also propose the management based on clinical and endoscopic findings.


Author(s):  
Norbert Lameire ◽  
Raymond Vanholder ◽  
Wim Van Biesen

The prognosis of acute kidney injury (AKI) depends on early diagnosis and therapy. A multitude of causes are classified according to their origin as prerenal, intrinsic (intrarenal), and post-renal.Prerenal AKI means a loss of renal function despite intact nephrons, for example, because of volume depletion and/or hypotension.There is a broad spectrum of intrinsic causes of AKI including acute tubular necrosis (ATN), interstitial nephritis, glomerulonephritis, and vasculitis. Evaluation includes careful review of the patient’s history, physical examination, urinalysis, selected urine chemistries, imaging of the urinary tree, and eventual kidney biopsy. The history should focus on the tempo of loss of function (if known), associated systemic diseases, and symptoms related to the urinary tract (especially those that suggest obstruction). In addition, a review of the medications looking for potentially nephrotoxic drugs is essential. The physical examination is directed towards the identification of findings of a systemic disease and a detailed assessment of the patient’s haemodynamic status. This latter goal may require invasive monitoring, especially in the oliguric patient with conflicting clinical findings, where the physical examination has limited accuracy.Excluding urinary tract obstruction is necessary in all cases and may be established easily by renal ultrasound.Distinction between the two most common causes of AKI (prerenal AKI and ATN) is sometimes difficult, especially because the clinical examination is often misleading in the setting of mild volume depletion or overload. Urinary chemistries, like calculation of the fractional excretion of sodium (FENa), may be used to help in this distinction. In contrast to FENa, the fractional excretion of urea has the advantage of being rather independent of diuretic therapy. Response to fluid repletion is still regarded as the gold standard in the differentiation between prerenal and intrinsic AKI. Return of renal function to baseline or resuming of diuresis within 24 to 72 hours is considered to indicate ‘transient, mostly prerenal AKI’, whereas persistent renal failure usually indicates intrinsic disease. Transient AKI may, however, also occur in short-lived ATN. Furthermore, rapid fluid application is contraindicated in a substantial number of patients, such as those with congestive heart failure.‘Muddy brown’ casts and/or tubular epithelial cell casts in the urine sediment are typically seen in patients with ATN. Their presence is an important tool in the distinction between ATN and prerenal AKI, which is characterized by a normal sediment, or by occasional hyaline casts. There is a possible role for new serum and/or urinary biomarkers in the diagnosis and prognosis of the patient with AKI, including the differential diagnosis between pre-renal AKI and ATN. Further studies are needed before their routine determination can be recommended.When a diagnosis cannot be made with reasonable certainty through this evaluation, renal biopsy should be considered; when intrarenal causes such as crescentic glomerulonephritis or vasculitis are suspected, immediate biopsy to avoid delay in the initiation of therapy is mandatory.


Author(s):  
Drew Provan ◽  
Trevor Baglin ◽  
Inderjeet Dokal ◽  
Johannes de Vos

History taking in patients with haematological disease - Physical examination - Splenomegaly - Lymphadenopathy - Unexplained anaemia - Patient with elevated haemoglobin - Elevated white blood cell (WBC) count - Reduced WBC count - Elevated platelet count - Reduced platelet count - Easy bruising - Recurrent thromboembolism - Pathological fracture - Raised ESR - Serum or urine paraprotein - Anaemia in pregnancy - Thrombocytopenia in pregnancy - Prolonged bleeding after surgery - Positive sickle test (HbS solubility test)


2020 ◽  
Vol 7 (2) ◽  
pp. e663 ◽  
Author(s):  
Tania Cellucci ◽  
Heather Van Mater ◽  
Francesc Graus ◽  
Eyal Muscal ◽  
William Gallentine ◽  
...  

ObjectiveAutoimmune encephalitis (AE) is an important and treatable cause of acute encephalitis. Diagnosis of AE in a developing child is challenging because of overlap in clinical presentations with other diseases and complexity of normal behavior changes. Existing diagnostic criteria for adult AE require modification to be applied to children, who differ from adults in their clinical presentations, paraclinical findings, autoantibody profiles, treatment response, and long-term outcomes.MethodsA subcommittee of the Autoimmune Encephalitis International Working Group collaborated through conference calls and email correspondence to consider the pediatric-specific approach to AE. The subcommittee reviewed the literature of relevant AE studies and sought additional input from other expert clinicians and researchers.ResultsExisting consensus criteria for adult AE were refined for use in children. Provisional pediatric AE classification criteria and an algorithm to facilitate early diagnosis are proposed. There is also discussion about how to distinguish pediatric AE from conditions within the differential diagnosis.ConclusionsDiagnosing AE is based on the combination of a clinical history consistent with pediatric AE and supportive diagnostic testing, which includes but is not dependent on antibody testing. The proposed criteria and algorithm require validation in prospective pediatric cohorts.


2015 ◽  
Vol 16 (2) ◽  
pp. 134-137 ◽  
Author(s):  
Thomas L. Beaumont ◽  
Jakub Godzik ◽  
Sonika Dahiya ◽  
Matthew D. Smyth

The authors report the case of a 14-year-old male with a subependymal giant cell astrocytoma (SEGA) that occurred in the absence of tuberous sclerosis complex (TSC). The patient presented with progressive headache and the sudden onset of nausea and vomiting. Neuroimaging revealed an enhancing left ventricular mass located in the region of the foramen of Monro with significant mass effect and midline shift. The lesion had radiographic characteristics of SEGA; however, the diagnosis remained unclear given the absence of clinical features of TSC. The patient underwent gross-total resection of the tumor with resolution of his symptoms. Although tumor histology was consistent with SEGA, genetic analysis of both germline and tumor DNA revealed no TSC1/2 mutations. Similarly, a comprehensive clinical evaluation failed to reveal any clinical features characteristic of TSC. Few cases of SEGA without clinical or genetic evidence of TSC have been reported. The histogenesis, genetics, and clinical approach to this rare lesion are briefly reviewed.


Blood ◽  
2006 ◽  
Vol 108 (11) ◽  
pp. 1478-1478
Author(s):  
Roseann Andreou ◽  
Tulay Koru-Sengul ◽  
Lori-Ann Linkins ◽  
Shannon M. Bates ◽  
Jeffrey S. Ginsberg ◽  
...  

Abstract BACKGROUND: As clinical assessment of pretest probability (PTP) is now considered the first step in the diagnostic evaluation of DVT it is important to know if the clinical features of DVT are the same in men and women. OBJECTIVES: We sought to answer the following questions: 1) Is the prevalence of DVT the same in men and women who are referred for diagnostic testing? 2) Are the clinical features of DVT the same in men and women? 3) Does the Wells’ clinical prediction model for first DVT perform similarly in men and women? METHODS: We performed a retrospective analysis of individual patient data from three studies that evaluated diagnostic testing in outpatients with a suspected first episode of DVT. Associations were assessed using univariable and multivariable analyses. RESULTS: A total of 1838 patients were eligible for final analyses, of whom 1132 (62%) were women and 706 (38%) were men. DVT was objectively diagnosed in 208 patients (11%). QUESTION 1: The prevalence of DVT was higher in men (14%) than in women (9%) (p=0.001). In a multivariable analysis that included eleven other clinical variables male gender was independently associated with a higher prevalence of DVT (OR 1.5, 95% CI 1.1–2.1). QUESTION 2: Of the confirmed episodes of DVT, “swelling of the entire leg” was observed more often in women (41%) than in men (16%) (p<0.001). This difference was partly explained by more extensive thrombosis in women than in men; the common femoral vein was involved on ultrasound in 48% of women and 22% of men (p< 0.001). The frequency of other clinical features was similar in men and women. QUESTION 3: The prevalence of DVT was higher in men than in women who were categorized by the Wells model as having a low PTP (6.9% vs 3.6%; p=0.025) or a moderate PTP (16.9% vs. 8.7%; p<0.001), but similar in the high PTP category (40% vs 44%; p=0.6). Five clinical features were more strongly associated with presence of DVT in women than in men: “swelling of the entire leg” (OR 7.7 vs. 1.6; p<0.001), “difference in calf circumference >3cm” (OR 8.2 vs. 2.9; p<0.001), “pitting edema” (OR 4.4 vs. 1.8; p=0.004), “age > 60 yrs” (OR 1.8 vs. 0.9; p=0.02) and “bedridden for greater than 3 days” (OR 3.7 vs. 1.4; p=0.05). CONCLUSIONS: Among outpatients referred with a suspected first episode of DVT, the prevalence of DVT is higher in men than in women but DVT is more extensive in women. Entire leg swelling is a more common and important sign of DVT in women than in men and the Wells prediction rule behaves differently in men than in women.


Sign in / Sign up

Export Citation Format

Share Document